Section Arrow
Quote
SLGL.NASDAQ
- Sol-Gel Technologies Ltd
Quotes are at least 15-min delayed:2026/06/06 00:15 EDT
Regular Hours
Last
 77.98
+3.61 (+4.85%)
Day High 
79.26 
Prev. Close
74.37 
1-M High
81.53 
Volume 
23.70K 
Bid
60
Ask
80.6
Day Low
73.8 
Open
73.8 
1-M Low
62.5 
Market Cap 
243.11M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 73.25 
20-SMA 71.07 
50-SMA 73.47 
52-W High 97.97 
52-W Low 6.8 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.30/-6.81
Enterprise Value
243.61M
Balance Sheet
Book Value Per Share
15.73
Cash Flow
Cash Flow Yield
0.00
Income Statement
Total Revenue
19.39M
Operating Revenue Per Share
0.38
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BCDABioCardia Inc.1.03+0.111+12.08%-- 
BGMSBio Green Med Solution Inc1.5+0.44+41.51%0.3PE
CMNDClearmind Medicine Inc.3.98+1.07+36.77%-- 
ADTXAditxt Inc.0.0621-0.0149-19.35%-- 
RXRXRecursion Pharmaceuticals3.315-0.485-12.76%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includesSGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease andother rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.